China Resources Medical Holdings Company Limited (stock code: 1515) announced on December 4, 2025, that it entered into a Healthcare Management Services Framework Agreement with China Resources (Holdings) Company Limited (CRH). The term of the agreement covers December 1, 2025, to December 31, 2027.
According to the announcement, members of CRH will procure healthcare management services from China Resources Medical Holdings Company Limited and its subsidiaries, including medical examinations and post-examination services. The pricing policy is based on market rates and normal commercial terms, with reference to published fee schedules and negotiated discounts.
The historical transaction amount from January 1, 2025, to October 31, 2025, was approximately RMB2.28 million. Looking ahead, the respective annual caps for these services under the new agreement are RMB20 million for the remainder of 2025, RMB100 million for 2026, and RMB170 million for 2027.
As CRH is a controlling shareholder of China Resources Medical Holdings Company Limited, the agreement constitutes continuing connected transactions under Chapter 14A of the Listing Rules. All applicable percentage ratios exceed 0.1% but fall below 5%, making the transactions subject to reporting, announcement, and annual review requirements.
Comments